« Previous
Next »
The Journal of Pain
Volume 11, Issue 2
, Pages 131-141
, February 2010
Guanosine Prevents Thermal Hyperalgesia in a Rat Model of Peripheral Mononeuropathy
References
- . Guanine nucleotides are competitive inhibitors of N-Methyl-D-Aspartate at its receptor site both in vitro and in vivo. J Pharmacol Exp Ther. 1989;250:162–169
- . Guanosine stimulates neurite outgrowth in PC12 cells via activation of heme oxygenase and cyclic GMP. Purinergic Signal. 2005;1:161–172
- . A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87–107
- . Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model. Brain Res. 2005;1041:38–47
- . Guanine nucleotides protect against kainate toxicity in an ex vivo chick retinal preparation. FEBS Lett. 1998;430:176–180
- . Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev. 2007;87:659–797
- . Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci Lett. 2008;431:101–105
- . Involvement of astrocytes in purine-mediated reparative processes in the brain. Int J Dev Neurosci. 2001;19:395–414
- . Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. Glia. 2000;29:202–211
- . Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia. 1999;25:93–98
- . Adenosine as a potential analgesic target in inflammatory and neuropathic pains. CNS Drugs. 2000;13:77–85
- . The antiapoptotic effect of guanosine is mediated by the activation of the PI 3-kinase/AKT/PKB pathway in cultured rat astrocytes. Glia. 2004;46:356–368
- . Purine nucleosides protect injured neurons and stimulate neuronal regeneration by intracellular and membrane receptor-mediated mechanisms. Drug Dev Res. 2001;52:303–315
- . Sustained depolarisation induces changes in the extracellular concentrations of purine and pyrimidine nucleosides in the rat thalamus. Neurochem Int. 2000;37:71–79
- . Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury. Eur J Pharm Sci. 2006;27:320–327
- . Purines and neutrophil leukocytes. Gen Pharmacol. 1997;28:345–350
- . Activation of glutamate uptake by guanosine in primary astrocyte cultures. Neuroreport. 2001;12:879–881
- . Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions. Cell Mol Neurobiol. 2002;22:353–363
- . Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. Brain Res. 2003;972:84–89
- . Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation. Neurochem Int. 1996;29:37–42
- . Spinal nerve ligation: What to blame for the pain and why. Pain. 2000;84:117–120
- . Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMP-dependent and -independent mechanisms. Neurosci Lett. 1996;220:175–178
- . A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88
- . ATP receptors in pain sensation: Involvement of spinal microglia and P2X(4) receptors. Purinergic Signal. 2005;1:95–100
- . Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury. Purinergic Signal. 2007;3:411–421
- . Metabolism and distribution of guanosine given intraperitoneally: Implications for spinal cord injury. Nucleosides Nucleotides Nucleic Acids. 2008;27:673–680
- . Guanosine promotes myelination and functional recovery in chronic spinal injury. Neuroreport. 2003;14:2463–2467
- . Vecht ChJ, Holstege JC: Intrathecal injection of GDNF and BDNF induces immediate early gene expression in rat spinal dorsal horn. Exp Neurol. 2005;194:255–266
- . Adenosine, inosine, and guanosine protect glial cells during glucose deprivation and mitochondrial inhibition: Correlation between protection and ATP preservation. J Neurochem. 1998;71:535–548
- . Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res. 2001;912:176–180
- . Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia. Brain Res. 1999;821:426–432
- . GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum. Neurosci Lett. 1997;225:145–148
- . The induction of pain: An integrative review. Prog Neurobiol. 1997;57:1–164
- . A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977;83:346–356
- . Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis. Neuroreport. 2004;15:833–836
- . Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions. J Neurosci. 2008;28:4261–4270
- . The serum S100B concentration is age dependent. Clin Chem. 2002;48:950–952
- . Trophic effects of purines in neurons and glial cells. Prog Neurobiol. 1999;59:663–690
- . Neurotrophic effects of extracellular guanosine. Nucleosides Nucleotides Nucleic Acids. 2008;27:666–672
- . Effects of guanine nucleotides on glutamate-induced chemiluminescence in rat hippocampal slices submitted to hypoxia. Neurochem Res. 1998;23:519–524
- . Guanosine impairs inhibitory avoidance performance in rats. Neuroreport. 2000;11:2537–2540
- . Amnesic effect of GMP depends on its conversion to guanosine. Neurobiol Learn Mem. 2006;85:206–212
- . Adenosine receptor activation and nociception. Eur J Clin Pharmacol. 1998;317:1–11
- . Adenosine in the spinal cord and periphery: Release and regulation of pain. Prog Neurobiol. 2003;69:313–340
- . Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice. Neurochem Res. 2005;30:69–73
- . Antinociceptive effects of intracerebroventricular administration of guanine-based purines in mice: Evidences for the mechanism of action. Brain Res. 2008;1234:50–58
- . Spinal mechanisms of antinociceptive action caused by guanosine in mice. Eur J Pharmacol. 2009;613:46–53
- . Guanosine and GMP prevent seizures induced by quinolinic acid in mice. Brain Res. 2000;864:40–43
- . Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol Ther. 2007;116:401–416
- . Anticonvulsant effect of GMP depends on its conversion to guanosine. Brain Res. 2004;1005:182–186
- . Effects of guanine nucleotides in kainic acid binding and on adenylate cyclase activity in chick optic tectum and cerebellum. J Mol Neurosci. 1991;3:39–46
- . Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci. 2003;23:2899–2910
- . Rat brain guanosine binding site: Biological studies and pseudo-receptor construction. Bioorg Med Chem. 2003;11:5417–5425
- . Specific [3H]-guanosine binding sites in rat brain membranes. Br J Pharmacol. 2002;135:969–976
- . Purine nucleoside-mediated protection of chemical hypoxia-induced neuronal injuries involves p42/44 activation. Neurochem Int. 2005;46:513–521
- . Oral administration of guanosine impairs inhibitory avoidance performance in rats and mice. Neurobiol Learn Mem. 2004;81:137–143
- . Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Res. 2003;977:97–102
- . Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats. J Neurosci Res. 2005;79:248–253
- . Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci. 2001;933:142–156
- . The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation: Implications for the treatment of post-injury pain hypersensitivity states. Pain. 1999;44:293–299
- . Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110
Supported by the FINEP research grant “Rede Instituto Brasileiro de Neurociência (IBN-Net)” #01.06.0842-00, CNPq, CAPES, FAPERGS, UFRGS.
PII: S1526-5900(09)00606-3
doi: 10.1016/j.jpain.2009.06.010
© 2010 American Pain Society. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Pain
Volume 11, Issue 2
, Pages 131-141
, February 2010
